Cite
Lin LL, Mick R, Ware J, et al. Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett. 2014;7(4):1151-1158doi: 10.3892/ol.2014.1855.
Lin, L. L., Mick, R., Ware, J., Metz, J., Lustig, R., Vapiwala, N., Rengan, R., & Kennedy, A. R. (2014). Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncology letters, 7(4), 1151-1158. https://doi.org/10.3892/ol.2014.1855
Lin, Lilie L, et al. "Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate." Oncology letters vol. 7,4 (2014): 1151-1158. doi: https://doi.org/10.3892/ol.2014.1855
Lin LL, Mick R, Ware J, Metz J, Lustig R, Vapiwala N, Rengan R, Kennedy AR. Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett. 2014 Apr;7(4):1151-1158. doi: 10.3892/ol.2014.1855. Epub 2014 Feb 05. PMID: 24944684; PMCID: PMC3961219.
Copy
Download .nbib